FDA
- Status: approved
Simulant agent for Zhi Kang Capsule (Simulant agent for Zhi Kang Capsule) regulatory status in United States.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA has authorised it.
Peking University People's Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.